Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 5/20 | 0.66 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.62 |
| ▸ | LMNA | P02545 | 1/20 | 0.62 |
| ▸ | PKM | P14618 | 1/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.62 |
| ▸ | SENP1 | Q9P0U3 | 1/20 | 0.60 |
| ▸ | CISD1 | Q9NZ45 | 1/20 | 0.54 |
| ▸ | SLC16A3 | O15427 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | SLC16A1 | P53985 | 1/20 | 0.54 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.54 |
| ▸ | NPC1 | O15118 | 2/20 | 0.53 |
| ▸ | RAB9A | P51151 | 2/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | LCK | P06239 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2058767 | 1.00 | EGFR (0.66) | EGFRKDM4ELMNAPKMKMT2A | |
| Phosphoric Acid SCHEMBL5329785 | 0.94 | EGFR (0.59) | EGFRKDM4ELMNAPKMKMT2A | |
| SCHEMBL21457670 | 0.86 | EGFR (0.58) | EGFRKDM4ELMNAPKMKMT2A | |
| SCHEMBL21457666 | 0.86 | EGFR (0.58) | EGFRKDM4ELMNAPKMKMT2A | |
| SCHEMBL11230443 | 0.84 | KDM4E (0.60) | EGFRKDM4ELMNAPKMKMT2A | |
| SCHEMBL30665832 | 0.83 | EGFR (0.55) | EGFRKDM4ELMNAPKMKMT2A | |
| SCHEMBL8830669 | 0.81 | EGFR (0.65) | EGFRKDM4ELMNAPKMKMT2A | |
| SCHEMBL8830671 | 0.81 | EGFR (0.65) | EGFRKDM4ELMNAPKMKMT2A | |
| SCHEMBL21457392 | 0.81 | EGFR (0.79) | EGFRKDM4ELMNAPKMKMT2A | |
| SCHEMBL10733520 | 0.81 | TRPA1 (0.61) | EGFRKDM4ELMNAPKMKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 364 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130023587-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER | DUKE UNIVERSITY (US) | 2013-01-24 | — | — | US | claimed |
| WO-2011123788-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER | DUKE UNIVERSITY (US) | 2011-10-06 | — | — | WO | claimed |
| WO-2010007443-A2 | METHODS OF DETERMINING PROPERTIES OF LATENT FINGERPRINTS | ROAR PARTICLES UK LTD (GB) | 2010-01-21 | — | — | WO | claimed |
| CN-122060644-A | Bacillus subtilis, application of bacillus subtilis in fermented soybean meal and preparation method of fermented soybean meal | 中粮营养健康研究院有限公司 | 2026-05-19 | — | — | CN | disclosed |
| EP-4588091-A1 | METHOD AND DEVICE FOR MONITORING AND CONTROLLING THE PERFORMANCE OF AN ION SOURCE | Bruker Daltonics GmbH & Co. KG (DE) | 2025-07-23 | — | — | EP | disclosed |
| WO-2025040657-A1 | SELECTIVE CYCLIZED PEPTIDE KAPPA-OPIOID RECEPTOR ANTAGONISTS | MEDIZINISCHE UNIVERSITÄT WIEN (AT) | 2025-02-27 | — | — | WO | disclosed |
| WO-2025040658-A1 | SELECTIVE CYCLIZED PEPTIDE KAPPA-OPIOID RECEPTOR AGONISTS | MEDIZINISCHE UNIVERSITÄT WIEN (AT) | 2025-02-27 | — | — | WO | disclosed |
| CN-119246663-A | Method for detecting drug-resistant genotyping of pseudomonas aeruginosa | 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） | 2025-01-03 | — | — | CN | disclosed |
| CN-117815401-B | Nanometer regulator combining photo-thermal effect and autophagy inhibition, preparation method and application | 四川省医学科学院·四川省人民医院 | 2024-05-31 | — | — | CN | disclosed |
| CN-117815401-A | Nanometer regulator combining photo-thermal effect and autophagy inhibition, preparation method and application | 四川省医学科学院·四川省人民医院 | 2024-04-05 | — | — | CN | disclosed |
| WO-2024056121-A1 | METHOD AND DEVICE FOR MONITORING AND CONTROLLING THE PERFORMANCE OF AN ION SOURCE | Bruker Daltonics GmbH & Co. KG (DE) | 2024-03-21 | — | — | WO | disclosed |
| WO-2001076618-A1 | MECHANICALLY ACTIVATED CHANNEL BLOCKER | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 2001-10-18 | — | — | WO | disclosed |
| US-6294367-B1 | NUCLEOTIDE SEQUENCES CODING ENZYMATIC POLYPEPTIDE; FOR USE IN SEQUENCE DETERMINATION OF POLYPEPTIDES | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2001-09-25 | — | — | US | disclosed |
| US-6130049-A | MEASURING ACTIVITY OF CATALYTIC ANTIBODIES BY CONTACTING PEPTIDE HAVING AT LEAST ONE ARGININE, LYSINE, OR PROLINE WITH TEST AND CONTROL SAMPLES AND PROMOTING CATALYTIC CLEAVAGE OF PEPTIDE; REDUCED ACTIVITY INDICATES DISEASE OR PREDISPOSITION | THE BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (US) | 2000-10-10 | — | — | US | disclosed |
| EP-0856065-A4 | ASSAY METHODS AND KITS FOR DIAGNOSING AUTOIMMUNE DISEASE | UNIV NEBRASKA (US) | 2000-05-31 | — | — | EP | disclosed |
| EP-0883405-A4 | AMIDINO PROTEASE INHIBITORS | DIMENSIONAL PHARM INC (US) | 1999-04-28 | — | — | EP | disclosed |
| EP-0883405-A1 | AMIDINO PROTEASE INHIBITORS | 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) | 1998-12-16 | — | — | EP | disclosed |
| EP-0856065-A1 | ASSAY METHODS AND KITS FOR DIAGNOSING AUTOIMMUNE DISEASE | UNIVERSITY OF NEBRASKA BOARD OF REGENTS (US) | 1998-08-05 | — | — | EP | disclosed |
| WO-1997024135-A1 | AMIDINO PROTEASE INHIBITORS | 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) | 1997-07-10 | — | — | WO | disclosed |
| WO-1997004125-A1 | ASSAY METHODS AND KITS FOR DIAGNOSING AUTOIMMUNE DISEASE | UNIVERSITY OF NEBRASKA BOARD OF REGENTS (US) | 1997-02-06 | — | — | WO | disclosed |